NCT00830115
Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders
See it on ClinicalTrials.gov ↗1,045 people
46%
54%
480 womenmiddle line = equal numbers563 men
- Phase
- —
- Paid for by
- Nycomed
- Finished
- 2009-06
- Health conditions
- Sleep Disorders, Non-Erosive Reflux Disease, Gastroesophageal Reflux Disease
- Who could join
- Anyone
- Ages
- 12 Years – no maximum
- Average age
- mean 52.9 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
No rules that kept women out were found.
Study titles and rules are shown in their original English.